News

Elevance Health (ELV) Gets a Buy from Barclays
In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Elevance Health price target raised to $522 from $512 at Barclays
Barclays raised the firm’s price target on Elevance Health (ELV) to $522 from $512 and keeps an Overweight rating on the shares following the ...
Elevance Health Inc. stock rises Tuesday, still underperforms market
The stock's rise snapped a four-day losing streak.
Becker's Spine Review1d
Resurgens Orthopaedics to open new location
Atlanta-based Resurgeons Orthopaedics is opening a new office in Braselton, Ga., according to an April 22 news release shared with Becker’s. The Braselton office, which is Resurgens’ 25th location in ...